Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma

被引:0
作者
Reinout H. de Roest
Marijke Stigter van Walsum
Karlijn van der Schilden
Ruud H. Brakenhoff
机构
[1] Amsterdam UMC Location Vrije Universiteit Amsterdam,Otolaryngology/Head and Neck Surgery, Head and Neck Cancer Biology and Immunology laboratory
[2] Nuclear Research and Consultancy Group,undefined
[3] Cancer Center Amsterdam,undefined
[4] Imaging and Biomarkers,undefined
来源
EJNMMI Research | / 14卷
关键词
Head and neck squamous cell carcinoma; Cisplatin; [195m]Platinum; Cisspect;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 166 条
[1]  
Rosenberg B(1965)Inhibition of Cell Division in Escherichia Coli by Electrolysis products from a platinum electrode Nature 205 698-9
[2]  
Vancamp L(1969)Platinum compounds: a new class of potent antitumour agents Nature 222 385-6
[3]  
Krigas T(1977)Cis-diamminedichloroplatinum (II). A new anticancer drug Ann Intern Med 86 803-12
[4]  
Rosenberg B(1977)CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck Cancer Treat Rep 61 359-66
[5]  
VanCamp L(2019)Best practice in systemic therapy for Head and Neck squamous cell carcinoma Front Oncol 9 815-21
[6]  
Trosko JE(2022)Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer Radiother Oncol 175 112-65
[7]  
Mansour VH(2017)The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma Eur Arch Otorhinolaryngol 274 3757-7
[8]  
Rozencweig M(2019)Cisplatin every 3 weeks Versus Weekly with definitive concurrent radiotherapy for squamous cell carcinoma of the Head and Neck J Natl Cancer Inst 111 490-20
[9]  
von Hoff DD(2005)Cellular processing of platinum anticancer drugs Nat Rev Drug Discov 4 307-84
[10]  
Slavik M(2007)The resurgence of platinum-based cancer chemotherapy Nat Rev Cancer 7 573-6